CN104997752A - 一种龙血竭速释胶囊及其制备方法 - Google Patents
一种龙血竭速释胶囊及其制备方法 Download PDFInfo
- Publication number
- CN104997752A CN104997752A CN201510382275.0A CN201510382275A CN104997752A CN 104997752 A CN104997752 A CN 104997752A CN 201510382275 A CN201510382275 A CN 201510382275A CN 104997752 A CN104997752 A CN 104997752A
- Authority
- CN
- China
- Prior art keywords
- sanguis draxonis
- quick
- release capsules
- preparation
- carrier material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 112
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 47
- 239000012876 carrier material Substances 0.000 claims abstract description 43
- 239000004094 surface-active agent Substances 0.000 claims abstract description 20
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 239000009286 sanguis draxonis Substances 0.000 claims description 108
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 45
- 235000010603 pastilles Nutrition 0.000 claims description 36
- 239000002245 particle Substances 0.000 claims description 18
- 229920001983 poloxamer Polymers 0.000 claims description 17
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 13
- 230000008018 melting Effects 0.000 claims description 12
- 238000002844 melting Methods 0.000 claims description 12
- 239000008118 PEG 6000 Substances 0.000 claims description 11
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 230000008014 freezing Effects 0.000 claims description 8
- 238000007710 freezing Methods 0.000 claims description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 7
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 claims description 5
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 31
- 238000004090 dissolution Methods 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000004927 fusion Effects 0.000 abstract 1
- 238000007711 solidification Methods 0.000 abstract 1
- 230000008023 solidification Effects 0.000 abstract 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 14
- 229960000502 poloxamer Drugs 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000009136 dragon's blood Substances 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 241001043298 Croton draco Species 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012738 dissolution medium Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- RSAIVLRELNGZEY-UHFFFAOYSA-N 3-(2,4-dimethoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one Chemical group COC1=CC(OC)=CC=C1CCC(=O)C1=CC=C(O)C=C1 RSAIVLRELNGZEY-UHFFFAOYSA-N 0.000 description 1
- 241000292342 Dracaena cochinchinensis Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- -1 as preferably Substances 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510382275.0A CN104997752B (zh) | 2015-06-30 | 2015-06-30 | 一种龙血竭速释胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510382275.0A CN104997752B (zh) | 2015-06-30 | 2015-06-30 | 一种龙血竭速释胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104997752A true CN104997752A (zh) | 2015-10-28 |
CN104997752B CN104997752B (zh) | 2018-07-20 |
Family
ID=54370798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510382275.0A Expired - Fee Related CN104997752B (zh) | 2015-06-30 | 2015-06-30 | 一种龙血竭速释胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104997752B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1265321A (zh) * | 2000-01-21 | 2000-09-06 | 广东名盛药业有限公司 | 中药血竭制剂及其制备方法 |
CN1698680A (zh) * | 2004-05-21 | 2005-11-23 | 金描真 | 改善血竭溶出度的给药系统 |
-
2015
- 2015-06-30 CN CN201510382275.0A patent/CN104997752B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1265321A (zh) * | 2000-01-21 | 2000-09-06 | 广东名盛药业有限公司 | 中药血竭制剂及其制备方法 |
CN1698680A (zh) * | 2004-05-21 | 2005-11-23 | 金描真 | 改善血竭溶出度的给药系统 |
Non-Patent Citations (1)
Title |
---|
张志荣: "《药剂学》", 31 December 2007, 北京:高等教育出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN104997752B (zh) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11152227A (ja) | フェノフィブレートを含んで成る改良された薬理組成物 | |
Kumar et al. | Self emulsifying drug delivery system (SEDDS): Future aspects | |
US5453283A (en) | Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation | |
WO2009043820A1 (de) | Hot melt-befüllte weichkapseln | |
US20100172969A1 (en) | Hot-melt micropellets | |
CN102793680A (zh) | 阿齐沙坦固体分散体及其制备方法和药物组合物 | |
CN102000018B (zh) | 一种含塞来昔布的固体分散物及其制备方法和应用 | |
CN103315960A (zh) | 基于球晶技术固体自微乳及其制备方法 | |
Gowda et al. | Preparation and Evaluation of Waxes/Fat Microspheres Loaded with Lithium Carbonate for Controlled Release. | |
BR112021016408A2 (pt) | Minimização de aeração de suspensões durante mistura em linha | |
CN101181224B (zh) | 一种恩替卡韦的固体分散体、其药物组合物及其制备方法和药物应用 | |
CN101375834B (zh) | 艾拉莫德的固体分散体及其制备方法和药物应用 | |
Parmar et al. | SMEDDS: A dominant dosage form which improve bioavailability | |
CN101134018A (zh) | 非诺贝特微丸及其制备方法 | |
JPS58109412A (ja) | ニフエジピン固形製剤 | |
CN101224211B (zh) | 恩替卡韦的固体分散体、药物组合物及其制备方法和药物应用 | |
US3883648A (en) | Method of making stable granules of N-4-{8 2-(5-chloro-2-methoxybenzamido)-ethyl{9 -phenylsulfonyl-N{40 -cyclohexyl urea and its salts and process for preparing same | |
CN103315961A (zh) | 新藤黄酸自微乳制剂及其制备方法 | |
CN104997752A (zh) | 一种龙血竭速释胶囊及其制备方法 | |
CN101292981A (zh) | 利莫那班的固体分散体、组合物及其制备和药物应用 | |
CN103655470A (zh) | 一种度他雄胺自微乳组合物及其制备方法 | |
JP2006517929A (ja) | 溶融アグロメレーションを用いてアグロメレートを製造する方法 | |
WO2007024123A1 (en) | Pharmaceutical composition of pranlukast solid-dispersion with improved initial dissolution rate and the method of preparing the same | |
US5525355A (en) | Laxative compositions | |
CN107126417A (zh) | 一种莪术醇固体分散体及其口服固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Lei Inventor after: Liu Yongli Inventor after: Chen Xiaofang Inventor after: Chen Yan Inventor after: Chen Chunxiao Inventor after: He Fan Inventor after: Xu Shanshan Inventor before: Chen Xiaofang Inventor before: Liu Yongli Inventor before: Shi Lei Inventor before: Chen Yan Inventor before: Chen Chunxiao Inventor before: He Fan Inventor before: Xu Shanshan |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180720 |